Trials / Completed
CompletedNCT00184756
Efficacy on Height in SGA Children Treated With Growth Hormone
Effect of Two Years Treatment With Growth Hormone on Height in SGA Children.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 151 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 3 Years – 7 Years
- Healthy volunteers
- Not accepted
Summary
This trial is conducted in Europe and Middle East. Growth hormone in SGA Children This trial compares a treated group of patients with an untreated group of patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | somatropin |
Timeline
- Start date
- 2002-11-01
- Primary completion
- 2006-07-01
- Completion
- 2006-07-01
- First posted
- 2005-09-16
- Last updated
- 2017-01-13
Locations
37 sites across 8 countries: Czechia, Finland, Germany, Israel, Poland, Portugal, Spain, Sweden
Source: ClinicalTrials.gov record NCT00184756. Inclusion in this directory is not an endorsement.